Morris & Dickson will distribute mpox vaccine Jynneos in the US

Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.

Jynneos was a driver of Bavarian Nordic’s 2023 revenue surge. Credits: Richard H Grant/Shutterstock.com

Following Bavarian Nordic’s announcement of the US commercial launch of its mpox (monkeypox) vaccine Jynneos (Imvanex/Imvamune), Morris & Dickson has shared that it will be the first US distributor of the vaccine for the rare viral disease.

According to the 3 March press release, the Caddo Parish, Louisiana-based wholesaler is receiving the first shipment of vaccines at an undisclosed date. Morris & Dickson has a storage and transport capability which is a “unique” attribute of the company’s distribution techniques. As per Jynneos’ label, the vaccine must be kept frozen at -25°C to -15°C and protected from light.

“Jynneos meets a critical public health need and helps ensure equitable access to healthcare, which in turn helps significantly prevent the spread of mpox to at-risk populations,” said head of Specialty at Morris & Dickson, Layne Martin in the announcement.

The two-dose, subcutaneously administered vaccine regimen, which first gained US Food and Drug Administration (FDA) approval in September 2019, was recommended for routine usage in adults with specific mpox infection risk factors by the Advisory Committee on Immunization Practices of the US Centers for Disease Control and Prevention (CDC) in October 2023. Previously, the committee recommended the vaccine for this population only at the time of an outbreak.

Jynneos is based on a live non-replicating MVA-BN strain of the modified vaccina virus Ankara which is not able to replicate in human cells and induces a strong cellular and humoral immune response. The vaccine has been a heavy contributor towards Bavarian Nordic’s revenue surge as the company reported a preliminary revenue of $1bn for 2023.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.